Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)DivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Change in Inventory (2025)

BridgeBio Pharma's Change in Inventory history spans 1 years, with the latest figure at $2.0 million for Q4 2025.

  • For Q4 2025, Change in Inventory changed N/A year-over-year to $2.0 million; the TTM value through Dec 2025 reached $25.3 million, changed N/A, while the annual FY2025 figure was $25.3 million, N/A changed from the prior year.
  • Change in Inventory for Q4 2025 was $2.0 million at BridgeBio Pharma, down from $6.8 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $13.4 million in Q2 2025 and bottomed at $2.0 million in Q4 2025.